The price transparency services business one person can now build to real scale, no patient data & no BAAs, by selling outcomes instead of dashboards in the lane Mark Cuban keeps pointing at.
🎧 Podcast episode for paid subscribers only. Also available on Spotify.
To listen to paid episodes in Apple or Spotify, link your Substack subscription via the show settings on those platforms (instructions inside the Substack app under Subscriptions → Podcast).
Table of Contents
(1) Nobody ever cut a check because of a dashboard
(2) What the files turned into in 2026, and why that suddenly matters
(3) Why selling the data is a footrace to zero
(4) The grunt work that used to make services a lousy business
(5) The one buyer who has to act whether they want to or not
(6) Why this sits in Cuban’s lane and almost nobody else’s
(7) How to stay on the side of the line that doesn’t need a lawyer
(8) What it does on a Tuesday, and why one person can run it
(9) Where it cracks, and what it will never fix
Abstract
Quick version. Healthcare price transparency data is now public, huge, and finally joinable, but the dozen companies selling access to it are stuck in a commodity knife fight and the buyers who get the data mostly do nothing with it. The unlock isn’t more data, it’s a thin services layer that acts on the data for the buyer, and the only reason that’s newly buildable by one person is that an agentic coding setup eats the data-engineering labor that used to gate services margins. Key facts in play. CMS started enforcing the upgraded hospital price transparency rule on April 1, 2026, hospitals must now encode their Type 2 NPI in the file and post actual dollar amounts at the median, 10th percentile, and 90th percentile where applicable, and CMS’s enforcement data still shows substantial noncompliance among hospitals. Mercer has 2026 employer health costs up 6.7% to at least $18,500 per worker, the worst in 15 years. Self-funded employers now carry CAA 2021 fiduciary exposure and the J&J suit proved an employee can sue over it. The big three PBMs run about 80% of claims. Cuban built Cost Plus on cost plus 15%, is backing the Break Up Big Medicine Act, and keeps warning the incumbents will game any reform unless someone forces and uses the transparency. The whole thing runs on public data, so it never touches PHI and never needs a BAA. That last constraint is the spine, not a footnote.
